<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230812059121N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-18</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of laser acupuncture on the quality of life of patients with temporomandibular disorders</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the quality of life and pain and maximum mouth opening in patients with temporomandibular disorders referring to the jaw and face pain clinic of Semnan Faculty of Dentistry with the complementary treatment of laser acupuncture.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71961</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In the first stage, patients are included in the study by meeting the criteria for entering the study. Therefore, our sampling method is easy at this stage. In the second stage, they are divided into two groups A and B using the block randomization method. Then, in the third step, using the table of random numbers, we determine which group will receive treatment and which group will receive placebo, Blinding description: The patients are informed that this plan is a study and includes two treatment and control groups, but they do not know about their group, and a dental student measures the variables of the study before and after the treatment, who is blind to the groupings. The executive officer of the plan informs the physiotherapist about the groups to use the laser for the treatment group and  the guiding light of the device for the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>temporomandibular disorders.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Laser therapy with LUMIX 2 HFPL low power diode laser machine made in Italy with wavelength nm810, output power mw500 and energy density j/cm2 21, frequency 13 kHz, output energy J 16.4 and modulation 100% with continuous waveform for 3 minutes. It takes 30 minutes for each acupuncture point, for a total of 10 points. The points under treatment include: GB20, SI19, ST6, ST7, LI4, which will be treated bilaterally. Both groups visit twice a week for a total of 10 sessions. Intervention 2: Control group: Only the guiding light of the device will be used as laser acupuncture in the same areas and with the same frequency and time as the first group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on the main outcome is shared

When:
شروع دوره دسترسی 4ماه پس از چاپ نتایج

To whom:
محققین شاغل در موسسات دانشگاهی و علمی

Conditions:
It can be used by mentioning the source

Where to obtain:
Maryam Shiransab with email address:shirin1998f@gmail.com

How to obtain:
Accept the request until 2 months later

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rasool Bagheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>hefdah shahrivar</address>
        <city>semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>35187-94431</zip>
        <telephone>+98 910 073 7438</telephone>
        <email>Rasool.bagheri@ymail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nahid Karbasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hefdeh Shahrivar Street</address>
        <city>semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3518794431</zip>
        <telephone>+98 913 397 8074</telephone>
        <email>sov.karbasi@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with a history of pain with VAS≥4 in masticatory muscles and/or temporomandibular joint during jaw movements or function (TMD muscle disorders (Class Ia, Ib) or anterior displacement of the disc with or without return (Class IIa, IIb) or arthralgia ( Class IIIa) based on (RDC/TMD)
Limitations in jaw movements (mouth opening &lt; 40 mm or side movements &lt; 8 mm)
Jaw sound while opening and closing the mouth
Deviation during opening and closing the mouth</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with a history of acute trauma
Patients who have been treated for temporomandibular joint disorders in the last month
Any pain with other origins such as decayed teeth, impacted teeth, other pathological lesions or neurological disorders in the head and neck area
People with congenital and neoplastic diseases in the TMJ range
People with joint diseases such as osteoarthritis and rheumatoid arthritis or suffering from hypermobility syndrome
Uncontrolled systemic problems with disability (ASA II or higher) including diabetes, thyroid disease, kidney disease, epilepsy and people with cerebrovascular problems
People with bleeding diseases or users of anticoagulants
Users of corticosteroid drugs
Cardiac patients or those with a pacemaker
Pregnant or breastfeeding mothers
Patients with psychiatric disorders such as severe depression and psychosis
Patients with any severe orthognathic deformities
Patients with posterior edentulousness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M26.60</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Temporomandibular joint disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Laser therapy with LUMIX 2 HFPL low power diode laser machine made in Italy with wavelength nm810, output power mw500 and energy density j/cm2 21, frequency 13 kHz, output energy J 16.4 and modulation 100% with continuous waveform for 3 minutes. It takes 30 minutes for each acupuncture point, for a total of 10 points. The points under treatment include: GB20, SI19, ST6, ST7, LI4, which will be treated bilaterally. Both groups visit twice a week for a total of 10 sessions.</i_keyword>
      <i_keyword>Control group: Only the guiding light of the device will be used as laser acupuncture in the same areas and with the same frequency and time as the first group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of life. Timepoint: The beginning and end of the study and One month after the last treatment session. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Maximum mouth opening. Timepoint: The beginning and end of the study and One month after the last treatment session. Method of measurement: Ruler with millimeter division.</prim_outcome>
      <prim_outcome>Pain. Timepoint: The beginning and end of the study and One month after the last treatment session. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Faculty of Physiotherapy</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-17</approval_date>
        <contact_name>Semnan University of Medical Sciences</contact_name>
        <contact_address>dental clinic،hefdah shahrivar Blvd semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
